Recent evidence from the Canadian health system asserts that universal vaccination decreased the burden of ILI [ 5, 6]; however, concerns remain in the United States about whether such efforts will be cost effective and whether there are enough immunization providers to achieve universal vaccination [ 7].
It is necessary to compare which mono-therapy (OST or NSP) is more cost effective, and whether mono-therapy is more cost effective than combined intervention – whether or not ART is offered.
8 The policy comprises proactive memory assessment of people in both primary care and acute hospital settings who may not have symptoms; however, there is little evidence that such initiatives, which inevitably lead to increased referrals to specialist services, are cost effective and whether they are distressing to patients.
The four conditions that Singh said homeopathy failed to meet were whether it was effective, whether it was cost-effective, whether there were cheaper alternatives, and whether it was so widely available on the high street it did not need to be prescribed.
If they're trying to be leaner, more efficient and more cost-effective, whether they're creating new operating procedures or products to sell externally to customers, there's a realignment there in that most things that are greener save money.
External stakeholders, such as governments and donor agencies, generally want to know whether targets are met, whether the approach is cost-effective, whether it compares favorably to alternative approaches, whether the project contributes to rural development, or whether it contributes to solving environmental and health problems or impediments to export of crops.
Apart from efficacy, questions remain regarding whether it is practical to deliver this method with the requisite quality and completeness of coverage on a larger scale than in experimental settings, whether it is cost-effective, whether it should be delivered as a stand-alone intervention or as an addition to IRS or LLINs, and whether this can be sustained for years.
The absence of trial evidence makes it impossible to determine whether or not mass screening for lung cancer would be cost effective and, indeed, whether a clinical trial to investigate the problem would be justified.
Decisions made by NICE about whether cost effective treatments are approved for use in the NHS usually apply a threshold of around £20 000-£30 000 per QALY.
The CCNTs were aware that their funding depended on whether they were seen to be cost effective, which depended on judgements about whether the children referred to them would otherwise have attended hospital.
